Status | Study |
RECRUITING |
Study Name: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects Condition: IgA Nephropathy Date: 2023-07-04 Interventions: Oral administration of specified dose of HS-10390 |
RECRUITING |
Study Name: A Study of BION-1301 in Adults With IgA Nephropathy Condition: IgA Nephropathy Date: 2023-05-02 Interventions: BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks. |
RECRUITING |
Study Name: Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy Condition: IgA Nephropathy Date: 2023-04-18 Interventions: Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo |
RECRUITING |
Study Name: Atacicept in Subjects With IgA Nephropathy Condition: IgA Nephropathy Date: 2021-01-11 Interventions: Once weekly subcutaneous (SC) injections by prefilled syringe |
Recruiting |
Study Name: IgA Nephropathy Registration Initiative of High Quality (INSIGHT) Condition: IgA Nephropathy Date: 2016-12-21 Interventions: Other: No intervention Registration of all IgAN patients in the First Affiliated Hospital of Sun Yat-sen |
Recruiting |
Study Name: Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA Nephropathy Condition: IgA Nephropathy Date: 2016-11-24 Interventions: Drug: Mycophenolate Mofetil le |
Recruiting |
Study Name: IgA Nephropathy Biomarkers Evaluation Study (INTEREST) Condition: IgA Nephropathy Glomerular Diseases Date: 2016-11-02 Interventions: Other: No intervention No intervention |
Recruiting |
Study Name: Efficacy and Safety of Atacicept in IgA Nephropathy Condition: IgA Nephropathy Date: 2016-06-16 Interventions: Drug: Atacicept 25 mg Subject |
Recruiting |
Study Name: Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy Condition: Primary IgA Nephropathy Date: 2016-04-30 Interventions: Drug: Hydroxychloroquine Sulfate |
Not yet recruiting |
Study Name: Integrative Medicine of IgA Nephropathy Condition: Primary IgA Nephropathy Date: 2015-11-17 Interventions: Drug: WM (Shentong Granules) S |